Boston Scientific Common stock, shares issued (in shares) increased by 0.1% to 1.7B in Q3 2025 compared to the prior quarter. Over 4 years (FY 2020 to FY 2024), Common stock, shares issued (in shares) shows relatively stable performance with a 0.9% CAGR.
other_common_stock_shares_issued| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B |
| QoQ Change | — | +0.2% | +0.0% | +0.2% | +0.0% | +0.1% | +0.1% | +0.2% | +1.5% | +0.1% | +0.0% | +0.3% | +0.2% | +0.3% | +0.1% | +0.1% |
| YoY Change | — | — | — | — | +0.5% | +0.4% | +0.5% | +0.5% | +1.9% | +1.9% | +1.9% | +0.5% | +0.5% | — | +0.5% | — |